Literature DB >> 20197792

Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening.

Yvonne Bombard1, Fiona A Miller, Robin Z Hayeems, Denise Avard, Bartha M Knoppers.   

Abstract

The expansion of newborn screening (NBS) has been accompanied by debate about what benefits should be achieved and the role of parental discretion in their pursuit. The opportunity to inform parents of reproductive risks is among the most valued additional benefits gained through NBS, and assumes prominence where the primary goal of identifying a treatable condition is not assured. We reviewed 53 unique guidelines addressing prenatal, preconception and newborn screening to examine: (1) how generating reproductive risk information is construed as a benefit of screening; and (2) what conditions support the realization of this benefit. Most preconception and prenatal guidelines - where generating reproductive risk information is described as a primary benefit - required that individuals be given a 'cascade of choices', ensuring that each step in the decision-making process was well informed, from deciding to pursue information about reproductive risks to deciding how to manage them. With the exception of three guidelines, NBS policy infrequently attended to the potential for reproductive benefits; further, most guidelines that acknowledged such benefits construed voluntarism narrowly, without attention to the choices attendant on receiving reproductive risk information. This review suggests that prenatal and preconception guidance identifies a coherent framework to support the pursuit of reproductive benefits through population screening programmes. Interestingly, attention to reproductive benefits is increasing among NBS guidance, yet reflection on how such benefits ought to be pursued remains limited. Traditional norms for NBS may require reconsideration where the remit of screening exceeds the primary goal of clinical benefits for infants.

Entities:  

Mesh:

Year:  2010        PMID: 20197792      PMCID: PMC2987364          DOI: 10.1038/ejhg.2010.13

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  30 in total

1.  Towards systematic reviews that inform health care management and policy-making.

Authors:  John Lavis; Huw Davies; Andy Oxman; Jean-Louis Denis; Karen Golden-Biddle; Ewan Ferlie
Journal:  J Health Serv Res Policy       Date:  2005-07

2.  Essentially Yours: The Protection of Human Genetic Information in Australia--the impact on clinical practice and the 'new genetics'.

Authors:  Ronald J A Trent
Journal:  Univ N S W Law J       Date:  2003

3.  Changing perspectives on the benefits of newborn screening.

Authors:  Donald B Bailey; Laura M Beskow; Arlene M Davis; Debra Skinner
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

4.  Newborn screening: toward a uniform screening panel and system--executive summary.

Authors: 
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

5.  From public health emergency to public health service: the implications of evolving criteria for newborn screening panels.

Authors:  Scott D Grosse; Coleen A Boyle; Aileen Kenneson; Muin J Khoury; Benjamin S Wilfond
Journal:  Pediatrics       Date:  2006-03       Impact factor: 7.124

6.  The expansion of newborn screening: is reproductive benefit an appropriate pursuit?

Authors:  Yvonne Bombard; Fiona A Miller; Robin Z Hayeems; Denise Avard; Bartha M Knoppers; Martina C Cornel; Pascal Borry
Journal:  Nat Rev Genet       Date:  2009-10       Impact factor: 53.242

Review 7.  Neonatal screening for sickle cell disorders: what about the carrier infants?

Authors:  L Laird; C Dezateux; E N Anionwu
Journal:  BMJ       Date:  1996-08-17

Review 8.  Genetic counseling.

Authors:  F C Fraser
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

9.  Newborn screening: complexities in universal genetic testing.

Authors:  Nancy S Green; Siobhan M Dolan; Thomas H Murray
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

Review 10.  Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs.

Authors:  Scott D Grosse; Coleen A Boyle; Jeffrey R Botkin; Anne Marie Comeau; Martin Kharrazi; Margaret Rosenfeld; Benjamin S Wilfond
Journal:  MMWR Recomm Rep       Date:  2004-10-15
View more
  23 in total

1.  Health-care providers' views on pursuing reproductive benefit through newborn screening: the case of sickle cell disorders.

Authors:  Yvonne Bombard; Fiona A Miller; Robin Z Hayeems; Brenda J Wilson; June C Carroll; Martha Paynter; Julian Little; Judith Allanson; Jessica P Bytautas; Pranesh Chakraborty
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

2.  Newborn screening for sickle cell disease: whose reproductive benefit?

Authors:  Lainie Friedman Ross
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

3.  Reply to Ross' commentary: Reproductive benefit through newborn screening: preferences, policy and ethics.

Authors:  Yvonne Bombard; Fiona A Miller
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

4.  Public views on participating in newborn screening using genome sequencing.

Authors:  Yvonne Bombard; Fiona A Miller; Robin Z Hayeems; Carolyn Barg; Celine Cressman; June C Carroll; Brenda J Wilson; Julian Little; Denise Avard; Michael Painter-Main; Judith Allanson; Yves Giguere; Pranesh Chakraborty
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

5.  Newborn Screening for Lysosomal Storage Disorders: Views of Genetic Healthcare Providers.

Authors:  Emily C Lisi; Shawn E McCandless
Journal:  J Genet Couns       Date:  2015-08-29       Impact factor: 2.537

Review 6.  International differences in the evaluation of conditions for newborn bloodspot screening: a review of scientific literature and policy documents.

Authors:  Marleen E Jansen; Selina C Metternick-Jones; Karla J Lister
Journal:  Eur J Hum Genet       Date:  2016-11-16       Impact factor: 4.246

Review 7.  Genomics and perinatal care.

Authors:  Joann Bodurtha; Jerome F Strauss
Journal:  N Engl J Med       Date:  2012-01-05       Impact factor: 91.245

8.  Biobank participant support of newborn screening for disorders with variable treatment and intervention options.

Authors:  Megan E Bunnell; Beth A Tarini; Michael Petros; Aaron J Goldenberg; Aishwarya Arjunan; Catherine Wicklund
Journal:  J Community Genet       Date:  2016-09-01

Review 9.  Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.

Authors:  Jeffrey R Botkin; John W Belmont; Jonathan S Berg; Benjamin E Berkman; Yvonne Bombard; Ingrid A Holm; Howard P Levy; Kelly E Ormond; Howard M Saal; Nancy B Spinner; Benjamin S Wilfond; Joseph D McInerney
Journal:  Am J Hum Genet       Date:  2015-07-02       Impact factor: 11.025

10.  Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).

Authors:  Stuart J Moat; Donald M Bradley; Rachel Salmon; Angus Clarke; Louise Hartley
Journal:  Eur J Hum Genet       Date:  2013-01-23       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.